DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Cash and Bank History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash and Bank | ₹3,715 Cr | ₹3,980 Cr | ₹4,214 Cr | ₹2,819 Cr | ₹2,156 Cr |
What is the latest Cash and Bank ratio of DIVIS LABORATORIES ?
Year | Cash and Bank |
---|---|
Mar2025 | ₹3,715 Cr |
Mar2024 | ₹3,980 Cr |
Mar2023 | ₹4,214 Cr |
Mar2022 | ₹2,819 Cr |
Mar2021 | ₹2,156 Cr |
How is Cash and Bank of DIVIS LABORATORIES Trending?
Years | Cash and Bank | % Change | |
---|---|---|---|
Mar2025 | ₹3,715 Cr | -6.66 | |
Mar2024 | ₹3,980 Cr | -5.55 | |
Mar2023 | ₹4,214 Cr | 49.49 | |
Mar2022 | ₹2,819 Cr | 30.74 | |
Mar2021 | ₹2,156 Cr | - |
Compare Cash and Bank of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹174,655.2 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,595.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
CIPLA | ₹126,894.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,685.0 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,373.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics | |
MANKIND PHARMA | ₹104,885.0 Cr | -4.9% | 8.9% | 21.3% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0.5% |
-1.2% |
45.5% |
SENSEX | -1.6% |
-3.4% |
0.9% |
You may also like the below Video Courses